Pharmaceutical Preparation Manufacturing federal obligations in New Jersey (NAICS 325412)

What the pharmaceutical manufacturing–New Jersey join is

NAICS 325412 and place-of-performance state NJ meet on this tie. $1,109,995,035 is the obligation sum on awards that carry both tags. It is not the nationwide total for pharmaceutical manufacturing, not New Jersey’s entire federal inflow, and not cash already paid. 325412 is pharmaceutical preparation manufacturing, not merchant wholesalers of drugs and not physician offices.

981 is an award-action count. Modifications, delivery orders, and repeat vehicles add rows. Unique vendors are not published in this packet. Dividing $1,109,995,035 by 981 yields about $1,131,493 per award on average. The join does not rank New Jersey against other states and does not assign a fiscal year; none is in the facts.

Open New Jersey federal spending for the state rollup, NAICS 325412 for the industry hub, New Jersey industries for other NAICS in the same geography, and All spending ties for other pairs.

NAICS 325412 as the industry side

USAspending labels NAICS 325412 as Pharmaceutical Preparation Manufacturing. Pharmaceutical preparation manufacturing covers finished-dose and related preparations as NAICS defines the class. The extract does not split vaccines, small molecules, or biologics, and it does not name products. Wholesale distribution is a 4242xx family, not this page. The industry hub for NAICS 325412 does not require New Jersey geography; only this overlay applies both filters.

A second pharmaceutical manufacturing join in another state uses the same NAICS and a different dollar total. Do not treat New Jersey’s 325412 figure as a synonym for every pharmaceutical manufacturing award in the catalog. 325412 is pharmaceutical preparation manufacturing, not merchant wholesalers of drugs and not physician offices. Award titles on the NAICS 325412 page are the place to see what a given line bought.

Place of performance in New Jersey

New Jersey on this join is a USAspending geography field, not a claim that every dollar was disbursed to New Jersey residents. New Jersey POP is statewide, not a single-corridor overlay. New York manufacturing with NY POP is another state. Place of performance is not an FDA approval census. Awards can list NJ while later performance occurs elsewhere.

The state hub for New Jersey shows how NAICS 325412 sits beside other industries in the same geography. This packet does not split metros, counties, or congressional districts. Open New Jersey federal spending for the state rollup, NAICS 325412 for the industry hub, New Jersey industries for other NAICS in the same geography, and All spending ties for other pairs.

Award count, mean, and obligations

981 awards is a mid-volume manufacturing file. Supply contracts and modifications add rows. The mean is not a wholesale acquisition cost per NDC. Award count 981 is a record count, not a payment count and not a unique-contractor census. Readers who need transaction-level detail should use the New Jersey industries list and the NAICS 325412 hub.

An obligation is a legal commitment. $1,109,995,035 is that kind of sum. Outlays can lag. This packet has no outlay total and no fiscal-year split. Citing $1,109,995,035 as cash already spent in New Jersey over-reads the field.

What this pair does not prove

Do not read the total as a drug-pricing finding or as medical advice. It is 325412 obligations with New Jersey POP. Outlays and list prices are not in the packet. Keep $1,109,995,035 labeled as NAICS 325412 obligations with New Jersey place of performance. Campaign contributions and USAspending awards are different datasets; this page does not claim donations fund these obligations.

A later ingest can restate $1,109,995,035 without changing the join key of NAICS 325412 and NJ. Rewrite only the sentence whose source moved. Open New Jersey federal spending for the state rollup, NAICS 325412 for the industry hub, New Jersey industries for other NAICS in the same geography, and All spending ties for other pairs. Correlation is not causation.

A clean footnote names the NAICS, the place-of-performance state, the obligation dollar total, and the award-action count on USAspending.gov. Keep the obligation word. Do not call the headline cash outlays. Metro folklore is not a packet split; awards stay statewide unless a different join says otherwise. A high award-action count is still a record count, including modifications. Original filings remain on the source site.

Questions

How much has NAICS 325412 obligated in New Jersey?

USAspending.gov records $1,109,995,035 in obligations for NAICS 325412 (Pharmaceutical Preparation Manufacturing) with New Jersey place of performance, covering 981 awards. That is an obligation total, not an outlay total, and not the nationwide pharmaceutical manufacturing figure. Original filings remain on USAspending.gov.

Does $1.11B mean the Treasury spent that much in New Jersey?

No. The figure is obligations on awards tagged to NAICS 325412 and New Jersey place of performance. Outlays can differ. Place of performance is a geography field, not proof that every dollar was disbursed to New Jersey vendors or residents. Original filings remain on USAspending.gov.

Does 325412 include New Jersey drug wholesalers?

No. 325412 is pharmaceutical preparation manufacturing. Merchant wholesale codes are separate. This join records $1,109,995,035 across 981 awards with New Jersey place of performance on 325412 only. Original filings remain on USAspending.gov This page does not invent a second NAICS total.

Where is the live pharmaceutical manufacturing–New Jersey table?

New Jersey federal spending is the state rollup. NAICS 325412 is the industry hub without a state filter. New Jersey industries lists other NAICS in New Jersey. All spending ties lists other pairs. The $1,109,995,035 and 981 awards on this page are the 325412×NJ join only. Original filings remain on USAspending.gov.